Rockefeller Capital Management L.P. Boosts Stake in HCA Healthcare, Inc. (NYSE:HCA)

Rockefeller Capital Management L.P. raised its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,090 shares of the company’s stock after purchasing an additional 440 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in HCA Healthcare were worth $9,380,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. Bangor Savings Bank raised its stake in HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares in the last quarter. MFA Wealth Advisors LLC acquired a new position in HCA Healthcare in the second quarter worth $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC grew its position in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after buying an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in HCA Healthcare in the second quarter valued at approximately $33,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts recently issued reports on the company. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research report on Tuesday, October 1st. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Wolfe Research raised HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. StockNews.com cut HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research report on Monday, November 4th. Finally, Morgan Stanley started coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $380.29.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. This represents a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last three months. 1.70% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $326.95 on Wednesday. HCA Healthcare, Inc. has a one year low of $250.67 and a one year high of $417.14. The stock has a fifty day moving average of $368.82 and a 200-day moving average of $358.90. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12. The company has a market capitalization of $82.82 billion, a PE ratio of 14.68, a price-to-earnings-growth ratio of 1.26 and a beta of 1.63.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. HCA Healthcare’s payout ratio is presently 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.